Promoting Radon Testing Among Mothers of Young Children
Part of paid clinical trials in Bismarck, North Dakota.
- Sponsor
- University of North Dakota
- Study ID
- NCT07591389
- Status
- Recruiting
Conditions
- Lung Cancer (Diagnosis)
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- The radon app — BEHAVIORALParticipants will be asked to use the radon app.
Study Details
Radon is the second-leading cause of lung cancer after smoking and may contribute to other cancer deaths; children are especially vulnerable due to a larger lung surface area and higher respiratory rates. The goal of this research is to test the feasibility of the radon app to promote radon testing among mothers of children aged 4 or younger when they receive a free radon test kit.
Key Dates
- Start date
- Apr 10, 2026
- Status verified
- May 2026
- Primary completion
- Aug 31, 2026
- Completion
- Dec 31, 2026
Study Design
- Enrollment
- 100 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- PREVENTION
Arms
- Experimental: The radon appParticipants will be encouraged to download the radon app and asked to use the radon app for four months where they will be exposed to mobile friendly educational content that is created from educational print brochures about radon published by EPA.
Primary Outcome Measure
T1 (baseline: pre-exposure survey, distribution of free radon test kit) [ Time Frame: Initial Enrollment to 2 months after enrollment ]
Central Contacts
- Soojung Kim Interim Dean, School of Graduate Studies, PhD, MPH701-777-2786
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of North Dakota Center for Family Medicine, Bismarck Clinic | Bismarck | North Dakota | 58501 | |
| University of North Dakota Center for Family Medicine, Minot Clinic | Minot | North Dakota | 58701 |
Find similar trials in Bismarck, ND
Related Studies
- Telehealth Collaborative Care Model (CoCM) in Lung CancerRecruiting · Abramson Cancer Center at Penn Medicine · Philadelphia, Pennsylvania
- SBU-RESET: RElaxation, Stress Reduction and Epigenetics Trial in Cancer SurvivorsRecruiting · Barbara Nemesure · Stony Brook, New York
- Evaluate the Clinical Performance of the Flow Cytometry - FlowPath Lung Test as a Sensitive and Specific Non-invasive Diagnostic of Sputum Samples to Identify/Detect the Presence of Lung Cancer in High-risk Individuals Who Have Existing Lung Nodules, 6 to <30 mm in Diameter, Determined by LDCT.Recruiting · bioAffinity Technologies Inc. · Palo Alto, California
- Building on Trust: Navigating Preventive Lung, Breast, and Prostate Cancer Screenings at Community Resource SpotsRecruiting · AdventHealth · Orlando, Florida